EUVIMEDEUVIMED entdecken
Crossref

Factores asociados a Esteatosis hepática no alcohólica en pacientes con tratamiento antirretroviral por VIH en un Hospital de Trujillo, Perú 2023

Yersin Silva Silva, Yersin Silva Silva

Revista Cientifica Internacional de Ciencias de la Salud · 31.03.2026 · 3 (1) · 4-13

DOI: 10.57188/ricsa.2026.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Cientifica Internacional de Ciencias de la Salud, online erschienen am 31.03.2026. Verfasst von Yersin Silva Silva und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective: analyze the risk factors associated with non-alcoholic fatty liver disease (NAFLD) in HIV patients during 2023. Material and Method: analytical, observational, cross-sectional, retrospective. The sample consisted of 141 patients diagnosed with HIV, treated at a hospital in Trujillo, among whom 42 cases of fatty liver disease were found. Factors such as obesity, DM II, disease treatment duration, coinfection with HBV and HCV, as well as a trend in gender, were observed. A chi-square test was performed, yielding a p-value of less than 0.005. A multivariate logistic regression analysis was used to adjust PR, using the SPSS program.

Results

Highlighting a prevalence of 29.79%. It was identified that age, gender (higher risk in men), the duration of antiretroviral treatment, and coinfections with HBV and HCV (X2 = 297.4) (p-value = 0.001) (X2 = 249.6) (p-value = 0.001) have a significant relationship with the presence of NAFLD. Additionally, type II diabetes mellitus and obesity are key factors, suggesting the importance of an integrated management approach to reduce the impact of NAFLD in this population.

Conclusions

They indicate that obesity and type II diabetes mellitus increase the risk of NAFLD in patients with HIV, while coinfection with HBV and, especially, with HCV also contributes to the development of this condition.

Zitieren

APA

Silva, Y. S., & Silva, Y. S. (2026). Factores asociados a Esteatosis hepática no alcohólica en pacientes con tratamiento antirretroviral por VIH en un Hospital de Trujillo, Perú 2023. Revista Cientifica Internacional de Ciencias de la Salud, 3(1), 4-13. https://doi.org/10.57188/ricsa.2026.002

Vancouver

Silva YS, Silva YS. Factores asociados a Esteatosis hepática no alcohólica en pacientes con tratamiento antirretroviral por VIH en un Hospital de Trujillo, Perú 2023. Revista Cientifica Internacional de Ciencias de la Salud. 2026;3(1):4-13. doi:10.57188/ricsa.2026.002

BibTeX
@article{Silva2026,
  author = {Silva, Yersin Silva and Silva, Yersin Silva},
  title = {Factores asociados a Esteatosis hepática no alcohólica en pacientes con tratamiento antirretroviral por VIH en un Hospital de Trujillo, Perú 2023},
  journal = {Revista Cientifica Internacional de Ciencias de la Salud},
  year = {2026},
  volume = {3},
  number = {1},
  pages = {4--13},
  doi = {10.57188/ricsa.2026.002}
}
Kostenlos starten →